NANDSC Membership Roster

NANDSC Membership Roster

Laurence F. Abbott, Ph.D., is the William Bloor Professor of Theoretical Neuroscience in the Department of Neuroscience and Department of Physiology and Cellular Biophysics at Columbia University, College of Physicians and Surgeons in New York City. Dr. Abbott uses computer simulation and mathematics to model individual neurons, their interactions within neural circuits, and to learn how those circuits combine to process and store information. He is a member of the National Academy of Sciences, and he has received several awards, including the NIH Director’s Pioneer Award, the Swartz Prize for Theoretical and Computational Neuroscience in 2010, and the Mathematical Neuroscience Prize in 2013; and he has served on several editorial boards including Neuron, Journal of Neuroscience, and Current Opinion in Neurobiology. Dr. Abbott received his Ph.D. in physics from Brandeis University in Waltham, Massachusetts.

Read More

 

Issam A. Awad, M.D., is the John Harper Seeley Professor of Surgery at the University of Chicago, Pritzker School of Medicine and is the director of neurovascular surgery at the University of Chicago Hospitals. Dr. Awad is an internationally recognized leader in neurosurgery, with an interest in the surgical management of neurovascular conditions that affect the brain and spinal cord. His research focuses on identifying molecular mechanisms that predispose patients to developing strokes or epilepsy and on ways to study the evolution of lesions in cerebral blood vessels. Dr. Awad earned his M.D. from Loma Linda University in California, and he completed his residency at the Cleveland Clinic Foundation in Ohio.

Read More

 

Christopher Bever, Jr., M.D.,, is a professor in the departments of Neurology and Physical Therapy and Rehabilitation Sciences at the University of Maryland School of Medicine in Baltimore. He is also the Director of the Department of Veterans Affairs (VA) Multiple Sclerosis Center of Excellence, East, and Associate Chief of Staff for Research and Development at the Baltimore VA Maryland Health Care System. Dr. Bever earned his medical degree from the University of Rochester in New York. He is a member of the American Neurological Association, the American Association for the Advancement of Science, and the American Academy of Neurology. His research focuses on developing therapies to treat the symptoms of multiple sclerosis. In addition, he is working with colleagues to develop robots to help with rehabilitation for neurological conditions.

Read More

 

Hollis T. Cline, Ph.D.,, is the chairman of the Department of Neuroscience and the Hahn Professor of Neuroscience, Departments of Molecular and Cellular Neuroscience, The Scripps Research Institute, La Jolla, California. Dr. Cline’s lab uses a wide range of advanced research techniques to study how sensory experience controls the wiring of the circuitry behind vision in the healthy and diseased brain. These techniques include genetically modifying individual brain cells, analyzing atomic level pictures of circuits, and monitoring neuronal activity with electrical recordings and real-time imaging. Dr. Cline is on the editorial boards for multiple journals and served as the president of the Society for Neuroscience in 2015-2016.

Read More

 

Susan Lloyd-Jones Dickinson, is the Executive Director of The Association for Frontotemporal Degeneration Radnor in Pennsylvania.

Gordon J. Fishell, Ph.D., is a Professor of Neurobiology at Harvard Medical School and the Stanley Center at the Broad Institute. Dr. Fishell earned his doctoral degree in Neurobiology from the University of Toronto in Canada. He is a Simons Investigator and has served on numerous editorial boards including the Journal of Neuroscience, Genes and Development, and Developmental Neuroscience. The focus of Dr. Fishell’s research is development, including ways in which specialized brain cells called interneurons contribute to differences across various brain regions and the genes involved in those processes.

Read More

 

David H. Gutmann, M.D., Ph.D., is the Donald O. Schnuck Family Professor in the Department of Neurology, and the Director of the Neurofibromatosis Center at Washington University in St. Louis. He earned a doctoral degree in microbiology and immunology as well as a medical degree from the University of Michigan in Ann Arbor. Over the past 20 years, Dr. Gutmann and his team have developed numerous mouse models of neurofibromatosis to define the cellular origins of tumors, the contribution of the tumor microenvironment, and the major growth control pathways that dictate brain development. He has been recognized for his achievements with numerous awards, including the 2012 Children’s Tumor Foundation Frederich von Recklinghausen Award, the 2013 Washington University Distinguished Faculty Research Award, and the 2014 Riley Church Lectureship.

Read More

 

David B. Hackney, M.D., is a professor in the Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston. He also serves as the Assistant Dean for Faculty Development and Professor of Radiology at Harvard Medical School. Dr. Hackney’s research interests include magnetic resonance imaging of spinal cord injury and image processing approaches to brain tumor volume measurement and characterization. He has served on numerous NIH federal advisory boards and is a fellow of the American College of Radiology and the International Society of Magnetic Resonance in Medicine.

Read More

 

Janet L. Hieshetter, has been the Executive Director of the Dystonia Medical Research Foundation (DMRF) since 2004. Ms. Hieshetter leads this organization that provides funding for dystonia research and works to collaborate with other patient advocacy organizations to provide resources for the scientific community. Prior to her work with the DMRF, Ms. Hieshetter served as Development Director for Trilogy, Inc., a mental health organization; Senior Director of Education for the National Osteoporosis Foundation, and Director of Field Services at the Alzheimer’s Association. Ms. Hieshetter is currently Chairperson of the Board of Directors of the American Brain Coalition, Co-chair of the Coalition of Patient Advocacy Groups of the Office of Rare Disease Research, and a member of the Executive Committee of the Dystonia Coalition.

Read More

 

Colonel Sidney R. Hinds, M.D., is the Brain Health Research Program Coordinator, DoD Blast Injury Research Program Coordinating Office and the Medical Advisor to the Principle Assistant for Research and Technology (PAR&T), Medical Research and Materiel Command at Fort Detrick, Maryland. He previously served as the National Director of the Defense and Veterans Brain Injury Center (DVBIC), a DoD-funded collaboration with the Department of Veterans Affairs. He represents the DoD at meetings of the NIH Advisory Council on Neurological Disorders and Stroke.

As the national director of the DVBIC, Col. Hinds oversaw the entire organization’s mission to serve active duty military and veterans with traumatic brain injury (TBI) through state-of-the-art medical care and care coordination and through innovative clinical research and educational programs. When he was deployed to Afghanistan in 2012, he served as the theater neurology consultant and oversaw the standardization of care at 11 concussion care centers.

Col. Hinds completed his neurology internship and residency at the former Walter Reed Army Medical Center and the National Naval Medical Center from 1996 to 2000. He was a staff neurologist and then chief of neurology at Landstuhl Regional Medical Center from 2000 to 2004. He completed the Walter Reed Nuclear Medicine Fellowship Program in 2006 and has been a staff nuclear medicine physician in the national capital region since that time.

Read More

 

Karen C. Johnston, M.D., is a professor of neurology and public health sciences and chair of the Department of Neurology at the University of Virginia. Dr. Johnston’s research interests involve acute stroke care, clinical trials, and assessing clinical outcomes, and her research has focused on treatment and outcomes in acute ischemic stroke. She has participated in many NIH-NINDS study sections and data safety monitoring committees and is chair of the NIH-NINDS clinical research collaboration advisory team. She served as an associate editor of the journal Neurology and is founding editor of the neurology resident and fellow section.

Read More

 

Bruce Ovbiagele, M.D., M.Sc., is the Chief of Staff at the San Francisco VA Health Care Stystem. Prior to joining the SFVAHCS, Dr. Ovbiagele served as professor and chairman of the Neurology Department at the Medical University of South Carolina. He earned his medical degree from the University of Lagos in Nigeria, and Master of Science in Clinical Research degree at the University of California, Los Angeles. In 2008, Dr. Ovbiagele was the recipient of the American Academy of Neurology Pessin Stroke Research Leadership award. Dr. Ovbiagele is an elected Fellow of the American Neurological Association, American Heart Association Stroke Council, American Academy of Neurology, and Royal College of Physicians (London). His primary research focus is the development and implementation of evidence-based behavioral interventions to improve outcomes for people with, or at risk for, stroke.

Read More

 

Steven Perrin, Ph.D., is the chief executive officer and chief scientific officer at the ALS Therapy Development Institute (ALS TDI) in Cambridge, Massachusetts. He earned his doctoral degree in biochemistry from Boston University Medical Center. Dr. Perrin moved into the pharmaceutical industry in 1997, holding positions at the Hoechst-Ariad Genomics Center, Aventis Pharmaceuticals in Cambridge and served as the Director of Molecular Profiling at Biogen Idec in Cambridge. He joined ALS TDI in 2007 as part of an historical collaboration between the Muscular Dystrophy Association, Augie's Quest and ALS TDI with the goal of developing a center ofexcellence for ALS drug development and translational research for neurodegenerative diseases. Under Dr. Perrin’s leadership, ALS TDI has assembled a scientific team that has brought two potential treatments into clinical development for ALS in the last seven years.

Read More

 

Indira M. Raman, Ph.D., is the Bill and Gayle Cook Professor of Biological Sciences in the Department of Neurobiology at Northwestern University in Evanston, Illinois. Currently, Dr. Raman studies the electrical properties of neurons in the cerebellum, a brain region important for the control of movements. Specifically, her lab is studying ways in which different neurons signal to each other as well as how their signaling changes during movement and while learning motor skills. She is the recipient of numerous awards and honors including the NINDS Jacob Javits Neuroscience Investigator Award, and she has served on several editorial boards including the Journal of Neuroscience, the Biophysical Journal, and eLife. Dr. Raman received her Ph.D. in neuroscience from the University of Wisconsin-Madison and did her postdoctoral training at the Vollum Institute in Portland, Oregon, and at Harvard Medical School, Boston.

Read More

 

Steven L. Roberds, Ph.D., is the Chief Scientific Officer of the Tuberous Sclerosis Alliance in Silver Spring, Maryland, a national voluntary health organization dedicated to finding a cure for and improving the lives of those affected by tuberous sclerosis complex (TSC), a genetic disorder that causes non-malignant tumors in the brain, eyes, heart, kidney, skin, and other organs. Since joining the TS Alliance in 2011, he has worked with scientists, clinicians, and members of industry, academia, and government agencies to advance research and treatments for TSC. Previously, Dr. Roberds served as an associate research fellow at Pfizer Global Research & Development and as a postdoctoral fellow in the Department of Physiology and Biophysics at the University of Iowa, Iowa City. He received his Ph.D. in pharmacology at Vanderbilt University School of Medicine in Nashville, Tennessee.

Read More